Burning Rock Biotech (BNR) Current Assets: 2020-2025
Historic Current Assets for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to $103.9 million.
- Burning Rock Biotech's Current Assets fell 7.14% to $103.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $418.6 million, marking a year-over-year decrease of 9.74%. This contributed to the annual value of $106.4 million for FY2024, which is 14.56% down from last year.
- Per Burning Rock Biotech's latest filing, its Current Assets stood at $103.9 million for Q3 2025, which was up 0.43% from $103.4 million recorded in Q2 2025.
- Over the past 5 years, Burning Rock Biotech's Current Assets peaked at $367.9 million during Q1 2021, and registered a low of $103.4 million during Q2 2025.
- Moreover, its 3-year median value for Current Assets was $111.8 million (2024), whereas its average is $121.0 million.
- As far as peak fluctuations go, Burning Rock Biotech's Current Assets tumbled by 38.44% in 2022, and later grew by 6.79% in 2025.
- MRQ analysis of 5 years shows Burning Rock Biotech's Current Assets stood at $285.7 million in 2021, then crashed by 36.13% to $182.5 million in 2022, then crashed by 31.77% to $124.5 million in 2023, then fell by 14.56% to $106.4 million in 2024, then decreased by 2.39% to $103.9 million in 2025.
- Its last three reported values are $103.9 million in Q3 2025, $103.4 million for Q2 2025, and $104.9 million during Q1 2025.